NA
Nascent Pharma Holdings, Inc.
NASC · OTC
$0.01 -13.94% (-$0.00)
1M +7.83%
Market Cap $910.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 3,406.45%
Asset turnover 0.00x
ROIC 107.66%
Debt
50 /100
Moderate Int. coverage -4.50x
Net debt/EBITDA -1.08x
Current ratio 0.02x
Stability
55 /100
Moderate Rev. volatility 76.26%
EPS volatility 15.06%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NASC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marco Alfonsi
Employees
12
Headquarters
Hicksville
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report